Enables promoter-specific chromatin binding activity. Acts upstream of or within negative regulation of type B pancreatic cell proliferation. Predicted to be located in centriolar satellite; nucleoplasm; and plasma membrane. Predicted to be active in nucleus. Is expressed in central nervous system and retina. Orthologous to human WDR13 (WD repeat domain 13). [provided by Alliance of Genome Resources, Apr 2022]